These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2650023)

  • 1. Cisplatin nephrotoxicity.
    Fillastre JP; Raguenez-Viotte G
    Toxicol Lett; 1989 Mar; 46(1-3):163-75. PubMed ID: 2650023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II).
    Laurent G; Yernaux V; Nonclercq D; Toubeau G; Maldague P; Tulkens PM; Heuson-Stiennon JA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(3):129-45. PubMed ID: 2899921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview. The nephrotoxicity of cisplatin.
    Goldstein RS; Mayor GH
    Life Sci; 1983 Feb; 32(7):685-90. PubMed ID: 6338333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin nephrotoxicity: experimental and clinical studies.
    Daugaard G
    Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum nephrotoxicity.
    Madias NE; Harrington JT
    Am J Med; 1978 Aug; 65(2):307-14. PubMed ID: 99034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of immunoreactive EGF and EGF receptor after acute tubular necrosis induced by tobramycin or cisplatin.
    Leonard I; Zanen J; Nonclercq D; Toubeau G; Heuson-Stiennon JA; Beckers JF; Falmagne P; Schaudies RP; Laurent G
    Ren Fail; 1994; 16(5):583-608. PubMed ID: 7855315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase.
    Vicente-Vicente L; Sánchez-Juanes F; García-Sánchez O; Blanco-Gozalo V; Pescador M; Sevilla MA; González-Buitrago JM; López-Hernández FJ; López-Novoa JM; Morales AI
    Toxicol Lett; 2015 Apr; 234(2):99-109. PubMed ID: 25677510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
    Goudie J; Chandra M; Lawrence GD; Williams P
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin nephrotoxicity in lead-pretreated rats: enzymatic and morphological studies.
    Bompart G; Orfila C
    Toxicol Lett; 1990 Feb; 50(2-3):237-47. PubMed ID: 2309243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
    Treskes M; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of lead and cadmium nephrotoxicity.
    Goyer RA
    Toxicol Lett; 1989 Mar; 46(1-3):153-62. PubMed ID: 2650022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gamma-Glutamyl transpeptidase excretion in cisplatin-induced acute renal failure.
    Gordon JA; Gattone VH; Schoolwerth AC
    Am J Kidney Dis; 1986 Jul; 8(1):18-25. PubMed ID: 2873743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin nephrotoxicity: insights into mechanism.
    Safirstein R; Winston J; Moel D; Dikman S; Guttenplan J
    Int J Androl; 1987 Feb; 10(1):325-46. PubMed ID: 3583421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of ferric nitrilotriacetate. An electron-microscopic and metabolic study.
    Hamazaki S; Okada S; Ebina Y; Fujioka M; Midorikawa O
    Am J Pathol; 1986 May; 123(2):343-50. PubMed ID: 3706495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP72 is an early biomarker to detect cisplatin and acetaminophen nephrotoxicity.
    Pérez-Villalva R; Barrera-Chimal J; Aguilar-Carrasco JC; Lima-Posada I; Cruz C; Ramírez V; González-Bobadilla Y; Uribe N; Trumper L; Bobadilla NA
    Biomarkers; 2017 Sep; 22(6):548-556. PubMed ID: 28393561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glycine on cisplatin nephrotoxicity and heat-shock protein 70 expression in the rat kidney.
    Musio F; Carome MA; Bohen EM; Sabnis S; Yuan CM
    Ren Fail; 1997 Jan; 19(1):33-46. PubMed ID: 9044450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of astaxanthin against cisplatin-induced nephrotoxicity in rats.
    Akca G; Eren H; Tumkaya L; Mercantepe T; Horsanali MO; Deveci E; Dil E; Yilmaz A
    Biomed Pharmacother; 2018 Apr; 100():575-582. PubMed ID: 29494988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.